Doxycycline propylaxis for human scrub typhus. 1982

J C Twartz, and A Shirai, and G Selvaraju, and J P Saunders, and D L Huxsoll, and M G Groves

The use of doxycycline, as a prophylactic antibiotic against scrub typhus was investigated in a prospective, randomized, double-blind study. Twenty volunteers were divided into two similar groups. Beginning three days before exposure to Leptotrombidium fletcheri chiggers infected with Rickettsia tsutsugamushi, and continuing for six weeks after exposure, one group received weekly 200-mg oral doses of doxycycline and the other group received a placebo. Nine of 10 doxycycline-treated subjects remained well during prophylaxis but developed antibody to scrub typhus, whereas nine of 10 subjects given the placebo required treatment for scrub typhus. Therefore, the efficacy of the regimen in preventing scrub typhus was 89% (eight cases prevented of nine expected). Ten days after successfully completing prophylaxis, eight of nine subjects reported minor self-limiting symptoms. A single dose of doxycycline was given on day 3 of illness to volunteers who developed scrub typhus. Such therapy was initially effective but was frequently followed by relapse and cannot be recommended.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004318 Doxycycline A synthetic tetracycline derivative with similar antimicrobial activity. 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-,Alpha-6-Deoxyoxytetracycline,Atridox,BMY-28689,BU-3839T,Doryx,Doxycycline Calcium,Doxycycline Calcium Salt (1:2),Doxycycline Hemiethanolate,Doxycycline Hyclate,Doxycycline Monohydrate,Doxycycline Monohydrochloride, 6-epimer,Doxycycline Monohydrochloride, Dihydrate,Doxycycline Phosphate (1:1),Doxycycline-Chinoin,Hydramycin,Oracea,Periostat,Vibra-Tabs,Vibramycin,Vibramycin Novum,Vibravenos,Alpha 6 Deoxyoxytetracycline,BMY 28689,BMY28689,BU 3839T,BU3839T,Doxycycline Chinoin,Doxycycline Monohydrochloride, 6 epimer,Vibra Tabs
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies

Related Publications

J C Twartz, and A Shirai, and G Selvaraju, and J P Saunders, and D L Huxsoll, and M G Groves
January 1978, Transactions of the Royal Society of Tropical Medicine and Hygiene,
J C Twartz, and A Shirai, and G Selvaraju, and J P Saunders, and D L Huxsoll, and M G Groves
March 2023, The New England journal of medicine,
J C Twartz, and A Shirai, and G Selvaraju, and J P Saunders, and D L Huxsoll, and M G Groves
June 2023, The New England journal of medicine,
J C Twartz, and A Shirai, and G Selvaraju, and J P Saunders, and D L Huxsoll, and M G Groves
June 2023, The New England journal of medicine,
J C Twartz, and A Shirai, and G Selvaraju, and J P Saunders, and D L Huxsoll, and M G Groves
June 2023, The New England journal of medicine,
J C Twartz, and A Shirai, and G Selvaraju, and J P Saunders, and D L Huxsoll, and M G Groves
May 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
J C Twartz, and A Shirai, and G Selvaraju, and J P Saunders, and D L Huxsoll, and M G Groves
September 2007, Antimicrobial agents and chemotherapy,
J C Twartz, and A Shirai, and G Selvaraju, and J P Saunders, and D L Huxsoll, and M G Groves
June 2023, The New England journal of medicine,
J C Twartz, and A Shirai, and G Selvaraju, and J P Saunders, and D L Huxsoll, and M G Groves
March 2011, Diagnostic microbiology and infectious disease,
J C Twartz, and A Shirai, and G Selvaraju, and J P Saunders, and D L Huxsoll, and M G Groves
January 2021, Indian journal of pediatrics,
Copied contents to your clipboard!